ARTICANZ - Beta (ver 0.91)
Annotated Registry of Trials in Cancer, Australia and New Zealand Ed.
- Results - location/QLD/4350-Toowoomba-Toowoomba-Hospital
Home
By cancer type
By drug class
By site
Data
FAQ
About
⚠
ARTICANZ provides informational content about cancer drug trials in Australia/NZ that is updated weekly but may not be completely accurate, and should not replace medical advice from qualified healthcare professionals. The platform is intended to be useful, providing information "as is" without warranties. Non-medical users must always consult healthcare providers for all clinical decisions.
Search results
8
trial(s) found.
NCT06846671
Haem
Phase 3
Recruiting
A Phase 3, Open-Label, Randomized Study of BGB-16673 Compared to Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab or Venetoclax Plus Rituximab Retreatment) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both BTK and BCL2 Inhibitors (
CaDAnCe-302
)
BTK PROTAC degrader
Bcl2 inhibitor
PI3K delta inhibitor
alkylating agent
anti-CD20 monoclonal antibody
Chronic lymphocytic leukaemia
Small lymphocytic lymphoma
NSW
2031 - Randwick - Prince of Wales Hospital
2139 - Concord - Concord Repatriation General Hospital
2250 - Gosford - Central Coast Cancer Centre, Gosford Hospital
2444 - Port Macquarie - Mid North Coast Cancer Institute-Port Macquarie Base Hospital
VIC
3004 - Melbourne, Southbank - Alfred Health
QLD
4350 - Toowoomba - Toowoomba Hospital
SA
5042 - Bedford Park - Flinders Medical Centre
WA
6005 - West Perth - Perth Blood Institute
NCT06452277
Advanced
Phase 3
Recruiting
A Phase 3 Open-label, Randomized, Active-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Orally Administered BAY 2927088 Compared With Standard of Care as a First-line Therapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With HER2-activating Mutations (
SOHO-02
)
EGFR/ERBB2 inhibitor,mutant-selective,non-covalent
Non-small cell lung cancer
NSW
2148 - Blacktown - Blacktown Hospital, Blacktown Cancer and Haematology Centre
2298 - Waratah - Calvary Mater Newcastle Medical Oncology
2139 - Concord - Concord Repatriation General Hospital (COMPLETED)
VIC
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre
QLD
4350 - Toowoomba - Toowoomba Hospital (WITHDRAWN)
4556 - Buderim - Sunshine Coast Haematology and Oncology Clinic (WITHDRAWN)
NCT06345079
Advanced
Phase 2
Recruiting
A Randomised Study of Cessation of Somatostatin Analogues After Peptide Receptor Radionuclide Therapy in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours (
STOPNET
)
Octreotide
cancer therapy
endocrine therapy
endocrine therapy,somastatin axis-targeting
somatostatin analog
Neuroendocrine tumour
NSW
2065 - St Leonards - Northern Sydney Cancer Centre, Royal North Shore Hospital
2500 - Wollongong - Wollongong Hospital
VIC
3000 - Melbourne - Peter MacCallum Cancer Centre
QLD
4006 - Herston - The Royal Brisbane and Women's Hospital Cancer Centre
4350 - Toowoomba - Toowoomba Hospital
4870 - Cairns - Cairns Base Hospital
SA
5011 - Woodville South - The Queen Elizabeth Hospital
WA
6150 - Murdoch - Fiona Stanley Hospital
6430 - Kalgoorlie-Boulder - Kalgoorlie Health Campus
NCT06252649
Advanced
Phase 3
Recruiting
Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb for Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301) (
CodeBreaK-301
)
KRAS G12C/NRAS G12C/HRAS G12C inhibitor
KRAS G12C inhibitor,OFF-state inhibitor
anti-EGFR monoclonal antibody
anti-VEGF monoclonal antibody
Colorectal cancer
NSW
2050 - Camperdown - Chris O'Brien Lifehouse
VIC
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre (TERMINATED)
QLD
4102 - Woolloongabba - Princess Alexandra Hospital
4350 - Toowoomba - Toowoomba Hospital
SA
5011 - Woodville South - The Queen Elizabeth Hospital
5042 - Bedford Park - Flinders Medical Centre
NCT06003621
Advanced
Phase 2
Recruiting
A Single Arm, Open-label, Phase II Signal-seeking Trial of Tiragolumab and Atezolizumab in Patients With Advanced Solid Tumours. (
MoST-TAP
)
anti-PD-L1 monoclonal antibody
anti-TIGIT monoclonal antibody
NOT Non-small cell lung cancer
Solid tumour
NSW
2444 - Port Macquarie - Mid North Coast Cancer Institute-Port Macquarie Base Hospital
2450 - Coffs Harbour - Coffs Harbour Health Campus - The North Coast Cancer Institute
2640 - Albury - Border Medical Oncology Research Unit
2800 - Orange - Orange Hospital-Cancer Centre Clinical Trials Unit
VIC
3220 - Geelong - Andrew Love Cancer Centre, University Hospital Geelong
3550 - Bendigo - Bendigo Health - Bendigo Cancer Centre
QLD
4350 - Toowoomba - Toowoomba Hospital
4700 - Rockhampton - Rockhampton Hospital
4814 - Douglas - Townsville Cancer Centre - The Townsville Hospital
4870 - Cairns - Cairns Base Hospital
WA
6150 - Murdoch - Fiona Stanley Hospital
TAS
7000 - Hobart - Royal Hobart Hospital
ACTRN12625000309482
Radonc
Phase 3
Recruiting
Accelerated Partial breast irradiation Using external beam Volumetric Modulated Arc Therapy (VMAT): a randomised non-inferiority trial of 30 Gy versus 26 Gy in five fractions investigating patient-reported outcomes. (
PUMA
)
Radiotherapy
cancer therapy
Breast cancer
NSW
2076 - Wahroonga - Sydney Adventist Hospital
VIC
3170 - Mulgrave - Icon Cancer Centre Mulgrave
QLD
4350 - Toowoomba - Toowoomba Hospital
SA
5087 - Windsor Gardens - Icon Cancer Centre Windsor Gardens
TAS
7000 - Hobart - Royal Hobart Hospital
ACTRN12625000201471
Haem
Phase 1 / Phase 2
Recruiting
ALLG MDS05 (MYDAS-T)/D3 (MESSAGE): Myelodysplasia Advancing Strategies in Therapy platform trial - Mesenchymal signal targeting in Myelodysplasia as a pathway to transfusion independence and blood count improvement (
MDS05-D3
)
Cedazuridine
DNA methyltransferase inhibitor
Decitabine
Sturlimogene Erparepvec
bispecific-EGFR/CDH17 antibody-drug conjugate
cancer therapy
cancer therapy,DNA methyltransferase-targeting
cancer therapy,cytidine deaminase-targeting
cytidine deaminase inhibitor
oncolytic herpes simplex virus
unknown drug class
Solid tumour
NSW
2050 - Camperdown - Chris O'Brien Lifehouse
2139 - Concord - Concord Repatriation General Hospital
2298 - Waratah - Calvary Mater Newcastle Medical Oncology
VIC
3004 - Melbourne, Southbank - Alfred Health
3066 - Epping - Northern Hospital
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre
QLD
4350 - Toowoomba - Toowoomba Hospital
SA
5000 - Adelaide - Royal Adelaide Hospital - Adelaide Cancer Centre
WA
6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre
ACTRN12624000963527
Advanced
Phase 2 / Phase 3
Recruiting
A randomised platform trial evaluating the role of interventions to prevent infection in patients with acquired hypogammaglobulinemia secondary to haematological malignancies -
RATIONAL-PT
(Stop-Ig Domain)
Doxycycline
tetracycline antibiotic
Haematological malignancy
NSW
2250 - Gosford - Central Coast Cancer Centre, Gosford Hospital
VIC
3066 - Epping - Northern Hospital
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre
3168 - Clayton - Monash Medical Centre
3550 - Bendigo - Bendigo Health - Bendigo Cancer Centre
QLD
4350 - Toowoomba - Toowoomba Hospital
SA
5000 - Adelaide - Royal Adelaide Hospital - Adelaide Cancer Centre
5042 - Bedford Park - Flinders Medical Centre
Additional search terms:
API and Webpage URLs:
Copy /Bookmark
Filters
Recruitment Status
Recruiting (8)
Recruitment Country and State
NSW (8)
QLD (7)
VIC (7)
SA (6)
WA (4)
TAS (2)
Phase
Phase 1 / Phase 2 (1)
Phase 2 (2)
Phase 2 / Phase 3 (1)
Phase 3 (4)
Trial Type
Advanced (5)
Haem (2)
Radonc (1)
Cancer Therapy Class
EGFR
25%
PD-1/PD-L1
25%
BTK
13%
Bcl2
13%
CD20
13%
PI3K delta
13%
ERBB2
13%
PD-1
13%
somastatin axis
13%
HRAS G12C
13%
KRAS
13%
NRAS G12C
13%
VEGF
13%
PD-L1
13%
TIGIT
13%
DNA methyltransferase
13%
cytidine deaminase
13%
Facility
4350 - Toowoomba - Toowoomba Hospital (8)
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre (4)
2139 - Concord - Concord Repatriation General Hospital (3)
5042 - Bedford Park - Flinders Medical Centre (3)
2250 - Gosford - Central Coast Cancer Centre, Gosford Hospital (2)
2444 - Port Macquarie - Mid North Coast Cancer Institute-Port Macquarie Base Hospital (2)
3004 - Melbourne, Southbank - Alfred Health (2)
2298 - Waratah - Calvary Mater Newcastle Medical Oncology (2)
4870 - Cairns - Cairns Base Hospital (2)
5011 - Woodville South - The Queen Elizabeth Hospital (2)
6150 - Murdoch - Fiona Stanley Hospital (2)
2050 - Camperdown - Chris O'Brien Lifehouse (2)
3550 - Bendigo - Bendigo Health - Bendigo Cancer Centre (2)
7000 - Hobart - Royal Hobart Hospital (2)
3066 - Epping - Northern Hospital (2)
5000 - Adelaide - Royal Adelaide Hospital - Adelaide Cancer Centre (2)
2031 - Randwick - Prince of Wales Hospital (1)
6005 - West Perth - Perth Blood Institute (1)
2148 - Blacktown - Blacktown Hospital, Blacktown Cancer and Haematology Centre (1)
4556 - Buderim - Sunshine Coast Haematology and Oncology Clinic (1)
2065 - St Leonards - Northern Sydney Cancer Centre, Royal North Shore Hospital (1)
2500 - Wollongong - Wollongong Hospital (1)
3000 - Melbourne - Peter MacCallum Cancer Centre (1)
4006 - Herston - The Royal Brisbane and Women's Hospital Cancer Centre (1)
6430 - Kalgoorlie-Boulder - Kalgoorlie Health Campus (1)
4102 - Woolloongabba - Princess Alexandra Hospital (1)
2450 - Coffs Harbour - Coffs Harbour Health Campus - The North Coast Cancer Institute (1)
2640 - Albury - Border Medical Oncology Research Unit (1)
2800 - Orange - Orange Hospital-Cancer Centre Clinical Trials Unit (1)
3220 - Geelong - Andrew Love Cancer Centre, University Hospital Geelong (1)
4700 - Rockhampton - Rockhampton Hospital (1)
4814 - Douglas - Townsville Cancer Centre - The Townsville Hospital (1)
2076 - Wahroonga - Sydney Adventist Hospital (1)
3170 - Mulgrave - Icon Cancer Centre Mulgrave (1)
5087 - Windsor Gardens - Icon Cancer Centre Windsor Gardens (1)
6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre (1)
3168 - Clayton - Monash Medical Centre (1)
Cancer Type
Cancer
Solid tumour
Haematological malignancy
B-cell lymphoma
B-cell malignancy
Chronic lymphocytic leukaemia
Leukaemia
Lymphoid leukaemia
Lymphoma
Mature B-cell malignancy
Non-Hodgkin's lymphoma
Small lymphocytic lymphoma
Lung cancer
Non-small cell lung cancer
Respiratory tract cancer
Thoracic cancer
Neuroendocrine tumour
Colorectal cancer
Gastrointestinal cancer
Lower gastrointestinal cancer
Breast cancer
URLs for this search
API URL:
Copy
Bookmarkable URL:
Copy